Interview with Dr Matt Dun on DIPG research and GDC-0084, page-9

I saw that trial not too long ago announced that it included the combination of ONC201 and panobinostat in the first arm. I believe Matt has previously used a combination of ONC201 and paxalasib.

It will be interesting to see if there are further updates on other possible combinations, and perhaps even more interesting to see those interim results from the Phase 1 DIPG trial.